Soligenix Reveals Formation Of European Medical Advisory Board To Provide Additional Medical/Clinical Strategic Guidance; Phase 3 Clinical Study Of HyBryte In CTCL Initiating In 2024
Soligenix Reveals Formation Of European Medical Advisory Board To Provide Additional Medical/Clinical Strategic Guidance; Phase 3 Clinical Study Of HyBryte In CTCL Initiating In 2024
soligenix透露成立欧洲医疗顾问委员会,提供额外的医疗/临床战略指导;HyBryte在2024年开始进行CTCL的第三阶段临床研究。
Soligenix Reveals Formation Of European Medical Advisory Board To Provide Additional Medical/Clinical Strategic Guidance; Phase 3 Clinical Study Of HyBryte In CTCL Initiating In 2024
Soligenix公布成立欧洲医疗顾问委员会,以提供额外的医疗/临床战略指导;HyBryte在CTCL的第三阶段临床研究将于2024年启动。